Business Wire

Maison Heler Metz Joins Curio Collection by Hilton

Jaa

Metz Mayor Dominique Gros, internationally acclaimed creator Philippe Starck and Hilton unveiled plans for the distinctive, Maison Heler Metz, Curio Collection by Hilton. The 14-story hotel, which will operate under Curio Collection by Hilton in a landmark agreement unveiled at MIPIM, includes a €22.5 million investment led by Yvon Gérard and a consortium of investors.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180315005715/en/

Maison Heler Metz Joins Curio Collection by Hilton. (Photo: Business Wire)

Maison Heler Metz Joins Curio Collection by Hilton. (Photo: Business Wire)

“Maison Heler Metz is a unique property, the design of which perfectly captures the spirit of our handpicked Curio Collection by Hilton hotels. This will be Metz’s first high-end hotel opening in a number of years, and an impressive addition to our portfolio in France, which continues to be the most visited country in the world,” said Patrick Fitzgibbon, senior vice president, development, EMEA, Hilton.

Curio Collection by Hilton is made up of nearly 50 remarkable hotels selected for their unique character and celebrated for their individuality. Maison Heler Metz joins more than 20 Curio Collection by Hilton hotels, trading or under construction properties in Europe.

“Metz is going through a revival. The opening of the Centre Pompidou Metz and the wider Quartier de l'Amphithéâtre redevelopment is attracting investment and drawing household names such as Philippe Starck and Hilton’s Curio Collection,” said Dominique Gros, mayor of Metz. “It’s great to see projects of this caliber come to Metz and there are exciting times ahead for the city.”

In the heart of the newly developed Quartier de l'Amphithéâtre, Maison Heler Metz will be the first hotel entirely created and developed from the ground up by the French creator. Starck has imagined this extraordinary construction in resonance with the Centre Pompidou Metz, like a habitable, surreal and poetic work of art, becoming a strong symbol for the region.

“This project is an ‘out-of-scale’ phantasmagoric architecture,” said Philippe Starck. “It's a game about uprooted roots, a symbolic construction of the Lorraine region.”

The monolithic and monochromatic building topped by an 18th century traditional Alsatian home will be a unique destination for guests and local residents to enjoy. The house will rest atop the 14th floor and include a rooftop terrace and garden, peppered with local trees and offering breath-taking views over the entire city. The house will also hold a cozy and poetic restaurant and lounge bar. The 119 guest rooms and suites are comfortable and elegant, complemented by modern amenities including a fitness center as well as private meeting spaces.

“Philippe Starck is a pioneer of international design and we are very proud to be working with him on this project,” said Yvon Gerard, co-founder of Maison Heler and leader of the project.

The hotel is part of the social, ecological and economic development of Metz, in a new neighborhood dedicated to culture, housing and business. Located on Metz’s former freight station, Maison Heler Metz is the most ambitious urban planning development launched in the region for a century. As the first high-rise building (IGH) built in the Moselle region complying with the HQE – RT2012 High Environment Quality standards, Maison Heler Metz is situated with immediate proximity to the Centre Pompidou-Metz, the Muse shopping centre and the Congress Centre, which will all diversify and strengthen the attractiveness of this landmark hotel.

“Maison Heler Metz is a fantastic addition to the Quartier de l'Amphithéâtre. Improving the region’s hotel offerings, this property will be a destination in its own right,” said Jean-Luc Bohl, chairman of Metz Métropole.

Maison Heler Metz, Curio Collection by Hilton will be located at the ZAC Amphitheatre, 57000, Metz. More information on upcoming Curio Collection by Hilton openings is available at news.curiocollection.com/openings.

About Maison Heler
www.maisonheler.com

About Starck
www.starck.com / Facebook @StarckOfficial / Instagram @Starck

About Curio Collection by Hilton

Curio Collection by Hilton (curiocollection.com) is an upper upscale, global portfolio of nearly 50 one-of-a-kind hotels and resorts handpicked for their unique character. Curio Collection properties appeal to travelers seeking unexpected and authentic experiences, and the benefits of Hilton’s award-winning guest loyalty program, Hilton Honors. Read the latest brand and property stories at news.curiocollection.com; discover Curio Collection destinations through the eyes of locals with 48-hour itineraries at citiesbycurio.com; and connect with Curio Collection on facebook.com/curiocollection, instagram.com/curiocollection and twitter.com/curiocollection.

About Hilton

Hilton (NYSE: HLT) is a leading global hospitality company, with a portfolio of 14 world-class brands comprising more than 5,200 properties with more than 856,000 rooms, in 105 countries and territories. Hilton is dedicated to fulfilling its mission to be the world’s most hospitable company by delivering exceptional experiences – every hotel, every guest, every time. The company's portfolio includes Hilton Hotels & Resorts, Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Canopy by Hilton, Curio Collection by Hilton, DoubleTree by Hilton, Tapestry Collection by Hilton, Embassy Suites by Hilton, Hilton Garden Inn, Hampton by Hilton, Tru by Hilton, Homewood Suites by Hilton, Home2 Suites by Hilton and Hilton Grand Vacations. The company also manages an award-winning customer loyalty program, Hilton Honors. Hilton Honors members who book directly through preferred Hilton channels have access to instant benefits, including a flexible payment slider that allows members to choose exactly how many Points to combine with money, an exclusive member discount that can’t be found anywhere else, and free standard Wi-Fi. Visit newsroom.hilton.com for more information, and connect with Hilton on Facebook, TwitterLinkedInInstagram and YouTube.

Contact information

Padraig Crowley
Hilton
padraig.crowley@hilton.com
+44 207 856 8005

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

ExaGrid Nominated in Six Categories for the 2019 Network Computing Awards20.3.2019 15:00:00 EETTiedote

ExaGrid ®, a leading provider of intelligent hyperconverged storage for backup, today announced that it has been nominated in six categories for the 2019 Network Computing Awards. ExaGrid has become a finalist for Data Centre Product of the Year, The Return on Investment Award, Hardware Product of the Year, Product of the Year, The Customer Service Award, and Company of the Year. Voting to determine the winner in each category is underway now and closes on April 23. The results will be revealed at an evening award ceremony in London on May 2. ExaGrid’s model EX63000E backup storage appliance with data deduplication is a nominee in four categories. The model provides the largest scale-out system and offers up to a 2PB full backup with an ingest rate of 432TB/hr, which is three times faster than any other backup storage on the market. “We are thrilled to be nominated by IT staff, and recognized by Network Computing, in six prestigious categories this year,” said Bill Andrews, CEO and Pre

Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain Diseases20.3.2019 14:30:00 EETTiedote

Eos Biosciences, Inc. (Eos), a nanomedicines company developing an efficient and versatile nanobiologic particle-based platform technology (Eosomes), announced that the U.S. Patent and Trademark Office has granted Eos Biosciences Patent No. 10,183,078, relating to a novel approach of using HER3-targeted Eosomes as a shuttle system for transporting various classes of therapeutics across the blood-brain barrier for treatment of brain disorders, including brain cancer. The patent is owned by Cedars-Sinai Medical Center and is exclusively licensed to Eos Biosciences. Details of the system will be highlighted in an upcoming manuscript from Lali Medina-Kauwe, PhD, Professor, Department of Biomedical Sciences, Cedars-Sinai. Omar Haffar, Ph.D., Founder, President and Chief Executive Officer, commented, “We’re very excited by the issuance of this pivotal patent and look forward to receiving similar approvals in other countries. This patent adds to Eos’ considerable IP portfolio covering the Eos

Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics20.3.2019 13:45:00 EETTiedote

Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc. (NYSE: PFE) announced today that Pfizer has acquired a 15% equity interest in Vivet and secured an exclusive option to acquire all outstanding shares. Pfizer and Vivet will collaborate on the development of VTX-801, Vivet’s proprietary treatment for Wilson disease. Wilson disease is a devastating, rare, chronic, and potentially life-threatening liver disorder of impaired copper transport that causes serious copper poisoning. In patients with Wilson disease, a monogenetic mutation disables the normal copper biliary excretion pathway leading to excess copper accumulation in the liver and other organs including the central nervous system. Untreated, Wilson disease results in various combinations and severity of hepatic (fibrosis and cirrhosis), neurologic and psychiatric symptoms, which can b

Fintech Company Rimilia Appoints Kevin Kimber as CEO20.3.2019 13:00:00 EETTiedote

Rimilia, a fintech company helping finance departments simplify the complex, has appointed Kevin Kimber as CEO. The news follows another strong year for Rimilia. In 2018, Rimilia opened offices in Central London and Denver, Colorado in the U.S., and reported significant revenue growth on the previous year. Rimilia was founded in 2008 and its platform, created by finance professionals, uses RPA (robotic process automation) technology to help finance teams fast-track their cash flow by providing clearer information and better control. It has quickly become the industry leader, trusted by a number of global brands from HSBC to DHL and Santander, to provide visibility, improve efficiencies and guarantee cash flow. Rimilia works with any currency, any bank and in any language, and on average delivers 70% cost-savings and an 80% reduction in manual effort to its customers. Kevin joins Rimilia from Eight Roads Ventures (one of Rimilia’s investors), where he was a Venture Partner, advising its

Knopp Biosciences Enters Collaboration with Leading UK Investigators to Commence Phase 2 Clinical Trial of Dexpramipexole in Severe Eosinophilic Asthma20.3.2019 13:00:00 EETTiedote

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high unmet need, today announced a collaboration with a consortium of leading medical researchers in the United Kingdom to evaluate the ability of Knopp’s lead drug candidate, dexpramipexole, to reduce exacerbations in people with severe eosinophilic asthma. The project is chiefly funded by the National Institute for Health Research (NIHR) and Medical Research Council (MRC) of the UK. The Chief Investigator for the Phase 2 multi-center, 52-week trial is Professor Salman Siddiqui, Professor of Airway Diseases at the University of Leicester and Consultant Respiratory Physician at Leicester’s Hospitals. Dexpramipexole is an orally available small molecule shown to selectively reduce eosinophil levels in multiple clinical trials, including in a Phase 2 study in hypereosinophilic syndrome (HES) and a Phase 2 trial in chr

SmartStream Partners with Cassini Systems to Help Firms Meet Uncleared Initial Margin Obligations20.3.2019 12:00:00 EETTiedote

SmartStream Technologies, the financial Transaction Lifecycle Management (TLM®) solutions provider, today announced its partnership with Cassini Systems, the leading provider of pre and post trade margin analytics for buy side derivatives trading, to help financial institutions comply with BCBS-IOSCO margin requirements for uncleared OTC derivatives. BCBS-IOSCO defines rules for margin requirements on Uncleared Over-the-Counter (OTC) derivatives known as Uncleared Margin Rules (UMR). ISDA has developed a Standard Initial Margin Model (SIMM) that can be used by market participants to provide a transparent and standardised margin methodology of bi-lateral trades. The roll out of UMR rules has now reached the buy side with phase 4 firms coming into scope in September 2019, and phase 5 firms in September 2020. SmartStream’s TLM Collateral Management provides firms with automated data management to reduce operational risks associated with collateral management. This partnership will integra

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme